Literature DB >> 10582131

The epidemiology of lung cancer.

S Franceschi1, E Bidoli.   

Abstract

Lung cancer is the most frequent cancer worldwide, accounting for about 12% of all new cancer diagnoses in the two sexes combined. During the 1950s and 1960s clear evidence emerged that smoking was the cause of striking lung cancer increases. Risk of lung cancer increases approximately with the fourth power of duration of smoking and the square of the number of cigarettes smoked daily. Between 1990 and 1994, lung cancer mortality rates showed first decreases in the US and several European countries, including Italy, in men although not in women. Marked shifts are, however, taking place in the incidence of different histologic types. Adenocarcinoma, which had always been the predominant type in women and non-smokers, is increasingly associated with tobacco smoking. Since the 1950s steady rises in the incidence of adenocarcinoma of the lung have been observed in many developed countries. Increases are similar in the two sexes and have followed a clear cohort pattern, paralleling changes in smoking habits and cigarette design more than diagnostic advances. Low-yield filter cigarettes tend to be inhaled more deeply than high-yield cigarettes in order to satisfy a craving for nicotine. The peripheral part of the lung, where most adenocarcinomas arise, is thus exposed to a disproportionately higher amount of smoke carcinogens. The hazards of light and ultra-light cigarettes tend to be underestimated, whereas the only safe cigarette is the non-smoked one.

Entities:  

Mesh:

Year:  1999        PMID: 10582131     DOI: 10.1093/annonc/10.suppl_5.s3

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  19 in total

1.  Cigarette nicotine yields and nicotine intake among Japanese male workers.

Authors:  K Ueda; I Kawachi; M Nakamura; H Nogami; N Shirokawa; S Masui; A Okayama; A Oshima
Journal:  Tob Control       Date:  2002-03       Impact factor: 7.552

Review 2.  Leisure-time physical activity and lung cancer: a meta-analysis.

Authors:  Adonina Tardon; Won Jin Lee; Miguel Delgado-Rodriguez; Mustafa Dosemeci; Demetrius Albanes; Robert Hoover; Aaron Blair
Journal:  Cancer Causes Control       Date:  2005-05       Impact factor: 2.506

3.  The sociobiologic integrative model (SBIM): enhancing the integration of sociobehavioral, environmental, and biomolecular knowledge in urban health and disparities research.

Authors:  M Chris Gibbons; Malcolm Brock; Anthony J Alberg; Thomas Glass; Thomas A LaVeist; Stephen Baylin; David Levine; C Earl Fox
Journal:  J Urban Health       Date:  2007-03       Impact factor: 3.671

4.  The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer.

Authors:  Nadiyah Kazmi; Diana C Márquez-Garbán; Lilia Aivazyan; Nalo Hamilton; Edward B Garon; Lee Goodglick; Richard J Pietras
Journal:  Lung Cancer Manag       Date:  2012-12

5.  Adjustment for smoking does not alter the FOXO3A association with longevity.

Authors:  Carolin Däumer; Friederike Flachsbart; Amke Caliebe; Stefan Schreiber; Almut Nebel; Michael Krawczak
Journal:  Age (Dordr)       Date:  2013-09-07

Review 6.  Standing the test of time in Europe? Gefitinib in the treatment of non-small-cell lung cancer.

Authors:  Caroline Wilson; Sarah J Danson
Journal:  Lung Cancer (Auckl)       Date:  2010-05-12

7.  Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer.

Authors:  M Huang; R K Batra; T Kogai; Y Q Lin; J M Hershman; A Lichtenstein; S Sharma; L X Zhu; G A Brent; S M Dubinett
Journal:  Cancer Gene Ther       Date:  2001-08       Impact factor: 5.987

8.  Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma.

Authors:  Young Joo Lee; In Kyu Park; Moo-Suk Park; Hye Jin Choi; Byoung Chul Cho; Kyung Young Chung; Se Kyu Kim; Joon Chang; Jin Wook Moon; Hoguen Kim; Sung Ho Choi; Joo-Hang Kim
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-11       Impact factor: 4.553

9.  Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-12-01

10.  A pilot characterization of human lung NSCLC by protein pathway activation mapping.

Authors:  Angela Zupa; Giuseppina Improta; Alessandra Silvestri; Elisa Pin; Jianghong Deng; Michele Aieta; Pellegrino Musto; Donato Nitti; Enzo Mammano; Lance Liotta; Claudio Belluco; Julia Wulfkuhle; Emanuel Petricoin
Journal:  J Thorac Oncol       Date:  2012-12       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.